Alan Rembach

4.7k total citations
57 papers, 2.8k citations indexed

About

Alan Rembach is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Alan Rembach has authored 57 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Physiology, 25 papers in Psychiatry and Mental health and 8 papers in Molecular Biology. Recurrent topics in Alan Rembach's work include Alzheimer's disease research and treatments (34 papers), Dementia and Cognitive Impairment Research (23 papers) and Trace Elements in Health (7 papers). Alan Rembach is often cited by papers focused on Alzheimer's disease research and treatments (34 papers), Dementia and Cognitive Impairment Research (23 papers) and Trace Elements in Health (7 papers). Alan Rembach collaborates with scholars based in Australia, United States and United Kingdom. Alan Rembach's co-authors include Colin L. Masters, Victor L. Villemagne, Ralph N. Martins, Ashley I. Bush, James D. Doecke, Christopher Fowler, S. Lance Macaulay, Christopher C. Rowe, David Ames and Kathryn A. Ellis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Brain.

In The Last Decade

Alan Rembach

56 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Rembach Australia 31 1.4k 746 561 557 325 57 2.8k
Roberta Cecchetti Italy 29 1.4k 1.0× 1.0k 1.4× 218 0.4× 591 1.1× 471 1.4× 55 3.2k
Noel G. Faux Australia 21 930 0.7× 689 0.9× 335 0.6× 359 0.6× 218 0.7× 47 2.3k
Veer Bala Gupta Australia 33 1.3k 0.9× 1.2k 1.6× 439 0.8× 148 0.3× 380 1.2× 99 3.4k
Laila Abdullah United States 34 1.0k 0.7× 1.1k 1.5× 596 1.1× 142 0.3× 439 1.4× 90 2.9k
Matthew Schrag United States 29 930 0.7× 728 1.0× 205 0.4× 330 0.6× 493 1.5× 77 3.2k
Katrina Laughton Australia 19 1.2k 0.8× 478 0.6× 104 0.2× 621 1.1× 145 0.4× 22 2.0k
Yifeng Du China 27 896 0.6× 952 1.3× 617 1.1× 110 0.2× 520 1.6× 147 3.2k
Ju‐Hee Kang South Korea 32 1.3k 0.9× 1.1k 1.5× 383 0.7× 146 0.3× 235 0.7× 125 3.1k
Abdul Hye United Kingdom 32 1.9k 1.4× 1.3k 1.7× 923 1.6× 151 0.3× 540 1.7× 83 3.4k

Countries citing papers authored by Alan Rembach

Since Specialization
Citations

This map shows the geographic impact of Alan Rembach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Rembach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Rembach more than expected).

Fields of papers citing papers by Alan Rembach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Rembach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Rembach. The network helps show where Alan Rembach may publish in the future.

Co-authorship network of co-authors of Alan Rembach

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Rembach. A scholar is included among the top collaborators of Alan Rembach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Rembach. Alan Rembach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Kelly R., Paul Maruff, Alan Rembach, et al.. (2022). Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β. Neurobiology of Disease. 171. 105783–105783. 11 indexed citations
2.
Roberts, Blaine R., Monica Lind, Aaron Z. Wagen, et al.. (2017). Biochemically-defined pools of amyloid-β in sporadic Alzheimer’s disease: correlation with amyloid PET. Brain. 140(5). 1486–1498. 101 indexed citations
3.
François, Maxime, Michael Fenech, Philip Thomas, et al.. (2016). High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease. Current Alzheimer Research. 13(7). 787–799. 21 indexed citations
4.
Gu, Ben J., Xin Huang, Alan Rembach, et al.. (2016). Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer’s disease. Acta Neuropathologica. 132(3). 377–389. 46 indexed citations
5.
Gupta, Veer Bala, James D. Doecke, Eugene Hone, et al.. (2015). Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 3(1). 18–26. 30 indexed citations
6.
Gupta, Veer Bala, Andrea C. Wilson, Samantha C. Burnham, et al.. (2015). Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer s Research & Therapy. 7(1). 16–16. 17 indexed citations
7.
Buckley, Rachel F., Michael M. Saling, Kathryn A. Ellis, et al.. (2015). Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. Age and Ageing. 44(6). 1012–1019. 29 indexed citations
8.
Leifert, Wayne R., Alan Rembach, Ralph N. Martins, et al.. (2015). Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer’s Disease Risk. Journal of Alzheimer s Disease. 48(2). 443–452. 6 indexed citations
9.
Lim, Yen Ying, Victor L. Villemagne, Simon M. Laws, et al.. (2014). APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease. Molecular Psychiatry. 20(11). 1322–1328. 97 indexed citations
10.
Rembach, Alan. (2014). The search for a blood-based biomarker for Alzheimer disease. Nature Reviews Neurology. 10(11). 618–619. 3 indexed citations
11.
Faux, Noel G., Alan Rembach, James S. Wiley, et al.. (2014). An anemia of Alzheimer's disease. Molecular Psychiatry. 19(11). 1227–1234. 106 indexed citations
12.
Rembach, Alan, Andrew D. Watt, W.J. Wilson, et al.. (2014). An increased neutrophil–lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology. 273(1-2). 65–71. 91 indexed citations
13.
Rowe, Chris C., Vincent Doré, Pierrick Bourgeat, et al.. (2014). HIGHER AB BURDEN IN HEALTHY APOE-E4 CARRIERS IS ASSOCIATED WITH SUBJECTIVE MEMORY COMPLAINTS: RESULTS FROM THE FLUTEMETAMOL AND PIB AIBL COHORTS. Internal Medicine Journal. 44. 15–15. 1 indexed citations
14.
Gardener, Samantha L., Stephanie R. Rainey‐Smith, Mary Barnes, et al.. (2014). Dietary patterns and cognitive decline in an Australian study of ageing. Molecular Psychiatry. 20(7). 860–866. 107 indexed citations
15.
Ellis, Kathryn A., Paul Maruff, Ralph N. Martins, et al.. (2012). P3‐093: Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months. Alzheimer s & Dementia. 8(4S_Part_13). 2 indexed citations
16.
Faux, Noel G., Craig Ritchie, Adam P. Gunn, et al.. (2010). PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses. Journal of Alzheimer s Disease. 20(2). 509–516. 321 indexed citations
17.
Acevedo, Karla, Ya Hui Hung, Qiao‐Xin Li, et al.. (2010). Copper Promotes the Trafficking of the Amyloid Precursor Protein. Journal of Biological Chemistry. 286(10). 8252–8262. 85 indexed citations
18.
Turner, Bradley J., Julie D. Atkin, Manal A. Farg, et al.. (2005). Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis. Journal of Neuroscience. 25(1). 108–117. 154 indexed citations
19.
Rembach, Alan, Bradley J. Turner, Stephen J. Bruce, et al.. (2004). Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS. Journal of Neuroscience Research. 77(4). 573–582. 57 indexed citations
20.
Turner, Bradley J., et al.. (2003). Opposing effects of low and high‐dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice. Journal of Neuroscience Research. 74(4). 605–613. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Cecchetti Breakdown of academic impact, for papers by Noel G. Faux Breakdown of academic impact, for papers by Veer Bala Gupta Breakdown of academic impact, for papers by Laila Abdullah Breakdown of academic impact, for papers by Matthew Schrag Breakdown of academic impact, for papers by Katrina Laughton Breakdown of academic impact, for papers by Yifeng Du Breakdown of academic impact, for papers by Ju‐Hee Kang Breakdown of academic impact, for papers by Abdul Hye
Rankless by CCL
2026